For an adult patient (≥ 18 years, weight > 40 kg) without contraindications, what oral dose of sumatriptan is equivalent to 10 mg of rizatriptan?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Oral Sumatriptan Dose Equivalent to Rizatriptan 10mg

The oral sumatriptan dose most comparable to rizatriptan 10 mg is 50 mg, though rizatriptan 10 mg demonstrates superior efficacy on most outcome measures.

Direct Comparative Evidence

The available evidence from head-to-head trials consistently shows that rizatriptan 10 mg outperforms sumatriptan 50 mg on key efficacy endpoints 1, 2, 3. When directly compared:

  • Pain-free at 2 hours: Rizatriptan 10 mg achieved 40% vs sumatriptan 50 mg at 35% (p=0.009) 1
  • Symptom-free at 2 hours: Rizatriptan 10 mg achieved 33% vs sumatriptan 50 mg at 28% (p=0.003) 1
  • Time to pain relief: Rizatriptan 10 mg showed faster onset with odds ratio 1.10-1.22 compared to sumatriptan 50 mg 2, 3

Dosing Considerations

Standard Dosing

  • Rizatriptan: 5-10 mg orally, may repeat after 2 hours (maximum 30 mg/24 hours) 4, 5
  • Sumatriptan: 25-100 mg orally, may repeat after 2 hours (maximum 200 mg/24 hours) 4

Pharmacokinetic Differences

The superior performance of rizatriptan relates to its pharmacokinetic advantages 6:

  • Time to peak concentration: Rizatriptan reaches peak at 60-90 minutes vs sumatriptan at 2-3 hours 4
  • Bioavailability: Rizatriptan 45% vs sumatriptan 15% 6
  • This translates to faster onset and better overall response rates

Clinical Algorithm for Dose Selection

When switching from rizatriptan 10 mg to sumatriptan:

  1. Start with sumatriptan 50 mg as the most comparable dose
  2. If inadequate response after 2-3 migraine episodes, escalate to sumatriptan 100 mg
  3. Consider that even sumatriptan 100 mg may not match rizatriptan 10 mg efficacy (pain-free at 2 hours: 40% vs 33%, p=0.019) 1

Important caveat: While sumatriptan 50 mg is the closest equivalent, patients may require sumatriptan 100 mg to approach the efficacy they experienced with rizatriptan 10 mg, though this comes with increased adverse events 3.

Tolerability Profile

Rizatriptan 10 mg actually demonstrated fewer drug-related adverse events (33%) compared to sumatriptan 100 mg (41%, p=0.014) 3. Both medications share similar contraindications including ischemic vascular disease, vasospastic coronary disease, uncontrolled hypertension, and significant cardiovascular disease 4.

Special Populations

Propranolol users: Maximum rizatriptan dose is 5 mg (15 mg/24 hours) due to drug interactions 5. This further complicates direct equivalency calculations.

Pediatric patients (6-17 years, ≥40 kg): Both medications use 10 mg dosing in this weight category 5.

Related Questions

Is rizatriptan more potent than sumatriptan for acute migraine treatment?
In a migraine patient who normally uses Maxalt (rizatriptan), can subcutaneous sumatriptan be administered when Maxalt is unavailable?
What is the equivalent dose of rizatriptan (Maxalt) to sumatriptan (Imitrex)?
What is the best treatment approach for abortive migraine in a patient with a history of frequent or severe migraine episodes, considering potential contraindications such as cardiovascular disease or pregnancy?
What are the alternatives to sumatriptan (Imitrex) for migraine treatment?
According to NCCN guidelines, what is the recommended dosing schedule for paclitaxel (80 mg/m²) and carboplatin (AUC 2) administered on days 1, 8, and 15 of a 28‑day cycle?
What is the recommended chemotherapy regimen and dosing for breast cancer, including dose modifications for neutropenia, thrombocytopenia, neuropathy, and considerations for HER2‑positive and hormone‑receptor‑positive disease, as well as second‑line options?
How can I explain to a patient with a prior history of gastric intestinal metaplasia that a recent endoscopic gastric biopsy was negative for intestinal metaplasia, yet they may still have the condition and require surveillance?
What is the appropriate evaluation and management for a pregnant patient presenting with left lower back pain?
What does the aVR lead represent on an electrocardiogram and what is the clinical significance of its abnormalities?
What pathologies can cause perforation of the terminal ileum?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.